Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2017: 100.00
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2016.5(5): 392-399
DOI: http://dx.doi.org/10.20546/ijcmas.2016.505.040


Is Spontaneous Bacterial Peritonitis still Responding to Third Generation Cephalosporins? : A Single Centre Experience
Sherief Abd-Elsalam1*, Hanan Soliman1, Walaa Elkhalawany1, Haidy Khalil2, Samah Soliman1, Eslam Ismail1 and Loai Mansour1
1Tropical Medicine & Infectious Diseases department, Tanta University Faculty of Medicine, Tanta, Egypt
2Microbiology department, Tanta University Faculty of medicine, Tanta, Egypt
*Corresponding author
Abstract:

The aim of this study was to assess the response of patients with SBP to third-generation cephalosporins in Nile delta. Current international guidelines recommend the use of a third-generation cephalosporin for empirical treatment of SBP. However, reports about antibiotic resistance for third-generation cephalosporins increased dramatically. Which raise the questions about these guidelines and if they are still valid. One hundred patients with liver cirrhosis, ascites and first episode of SBP signed informed consent to participate in this study. They were admitted to Department of Tropical Medicine and Infectious diseases-Tanta University hospital for one week during the period from January to December 2014. The patients were randomly assigned to receive either cefotaxime 2 gm every 12 hours or ceftriaxone 2 gm every 24 hours. Their ascitic fluid samples were re-examined after 48 hours and after 5 days to assess the response to third-generation cephalosporins. On assessment of the response to third-generation cephalosporins after 48 hours, 65% of patients had satisfactory response (decrease 25% at least in PMNL count) while 35% did not achieve a satisfactory response and were shifted to another antibiotic. After 5 days, only 46/65of initial responders achieved complete response. Ceftriaxone had higher response rates than Cefotaxime. However, this difference was non-significant.  Based on our study, There is a dramatic decrease in the response rate of SBP to third-generation cephalosporins. This marked decrease in the response should be watched closely as it suggests re-considering of the current guidelines for empiric therapy in SBP. (Clinical Trials.gov Identifier: NCT02443285).


Keywords: Liver cirrhosis, Ascites, Spontaneous bacterial peritonitis, 3rd generation cephalosporins.
Download this article as Download

How to cite this article:

Sherief Abd-Elsalam, Hanan Soliman, Walaa Elkhalawany, Haidy Khalil, Samah Soliman, Eslam Ismail and Loai Mansour. 2016. Is Spontaneous Bacterial Peritonitis still Responding to Third Generation Cephalosporins? : A Single Centre ExperienceInt.J.Curr.Microbiol.App.Sci. 5(5): 392-399. doi: http://dx.doi.org/10.20546/ijcmas.2016.505.040